TABLE 2.
Variables | Low chemerin (n = 67) | Total high chemerin (n = 85) | P-value | Low chemerin (n = 43) | Non-CAD high chemerin (n = 32) | P-value | Low chemerin (n = 24) | CAD high chemerin (n = 53) | P-value |
MACEs | 12 | 44 | <0.001 | 6 | 9 | 0.120 | 6 | 35 | 0.003 |
Cardiac death | 1 | 6 | 0.077 | 0 | 2 | 0.101 | 1 | 4 | 0.466 |
NFMI | 5 | 12 | 0.141 | 3 | 2 | 0.945 | 2 | 10 | 0.193 |
Stroke | 4 | 14 | 0.008 | 2 | 5 | 0.087 | 0 | 7 | 0.044 |
Revascularization | 2 | 12 | 0.015 | 1 | 0 | 0.474 | 3 | 14 | 0.081 |
Data are n. MACE, major adverse cardiovascular events; NFMI, non-fatal myocardial infarction; CAD, coronary artery disease; P-values were derived using the log-rank test.